Roberto G. Carbone
Roberto Giovanni Carbone is an Italian scientist, physician and professor of Medicine, studying the mechanisms and treatment of pulmonary fibrosis including idiopathic pulmonary fibrosis genome, pulmonary hypertension, lung transplantation, lung cancer and translation basic research regarding stem cell in post-AMI.
Notable recognition includes nomination of Royal Society Fellowship in London, United Kingdom.
Alma Mater
University Imperial College
Early life and education
Carbone was born in Genoa, and was awarded Doctor in Medicine (DM) from the University of Genoa. in 1983. He moved to the Post-Graduate Medical School in 1987 and 1990 specialising in Pulmonary Diseases and Respiratory Pathophysiology respectively.
He spent twenty years as clinical researcher in the Department of Internal Medicine at the Regional Aosta Hospital. He progressed up the ranks from assistant to senior registrar and Deputy Head physician.
He obtained master’s degrees in
- asthma and COPD from the University of Ferrara
- respiratory disease and imaging from University of Montpellier,
- asthma at University of Denver
- pulmonary hypertension from University of Michigan
- respiratory medicine and bronchology from the National Heart and Lung Institute, Royal Brompton Hospital and Imperial College London under the supervision of Professors Margaret Turner Warwick and Peter Barnes.
Carbone completed his studies at Royal Brompton Hospital in Imperial College London and registered with the UK General Medical Council in 2003. His Mentors were Margaret Turner Warwick and Peter Barnes. Laterly he worked as clinical researcher at University of Genoa, and became a distinguished Professor of Medicine and senior consultant in cardio-respiratory physician at University of Genoa.
In 2023 he awarded Fellowship of the Royal Society in London, United Kingdom.
Research
His research initially focused on the study of alpha-1 antitrypsin deficiency pulmonary emphysema, and urinary degradation products (desmosine) and prolastin treatment working in the lab of Gordon L. Snider for the project The American-Italian AATD Study Group.[1](Harvard University).
Further, he dedicated himself to the study of lung cancer, creating the first Italian Cancer Registry with the patronage of the Istituto Superiore di Sanità in IST (Scientific Institute of Tumours) in Genoa under the direction of Leonardo Santi.[2] He studied pathologies associated with asbestos as pleural mesothelioma at Scansetti Interdepartmental Center in Turin University and highlighted the role of neurotensin in asthma adrenergic regulation with Giovanni Bottino in Genoa University.[3] Carbone explored the study of Indium[4] the higher accuracy with respect to tracer Gallium 67 applied in Interstitial Lung Disease. His findings were presented in USA on October 2001 at the World CHEST Meeting.[5]
His first book regrouped Pulmonary Arterial Hypertension and all Interstitial Lung Diseases identifying the former as cause of worse mortality in the progression of Interstitial Lung Disease. The book in English language is widely read internationally, and notably is held in Capitol Hill Library (Washington D.C.)[6], British Library, MIT in Boston, National Institute of Health, Moscow University and in China.[7]
His third book entitled Lung Transplantation - Evolving Knowledge and New Horizons, a collaboration with Mario Viganò opens with the first chapter entitled "The History of Lung Transplantation.”[8]
Carbone is collaborating with Genoa University and OSIC (Open Source Imaging Consortium) National Heart and Lung Institute, Imperial College, London. This collaboration is studying the correlation between IA and Imaging specifically High Resolution CT (HRCT) in interstitial lung disease.[9]
Carbone is a member of the IPF Collaborative Network: a Platform for IPF Genetics for University of Genoa, led by Principal Investigator David Schwartz MD from University of Colorado Anschutz Medical Campus. The scope of this program of work is to further understand the genetics of IPF by collecting more than 10,000 ethnically diverse cases of Idiopathic Pulmonary Fibrosis (IPF) with the collaboration of 70 international investigators (across 40 sites).[10]
Publications
Carbone[11] is the author[12] of over 150 publications[13] in peer-reviewed journals.[14] He was a member of the editorial board of the scientific journal CHEST and is an associate editor of the journal Frontiers[15] and Editorial Board of THE LANCET. His ORCID number 0000-0002-6633-9707 reported in SCOPUS over 1160 citations.[16]
Honors and awards
First prize, as speaker and author, 8th World Congress of Bronchology in Munich. Title of the study: "The open window thoracoscopy procedure for broncho-pleural fistula with persistent empyema following pneumonectomy".
First prize for the study “In vivo microenvironmental reactivity in asthma" with Giovanni Bottino at National Congress of CHEST (American College of Chest Physicians).
Carbone was appointed in a number of leadership roles at American College of Chest Physicians latterly representing Italy as Governor in the College.
Carbone was a member of the voluntary opera in the American delegation of the National Institute of Health (NIH) associated with People to People Ambassador Program. This was supported by Professor Claude Lenfant (Director of NIH) for scientific exchanges between United States and CHINA and thePresident of People to People (USA) Dr. Mary Jean Eisenhower.
Carbone was both a member and leader for the American Thoracic Society COPD National Quality Forum in USA. For these works Carbone received formal recognition from President of the American Thoracic Society in the World Meeting in Washington (DC) as the International Member representing Italy.
In 2017 Carbone was appointed Docent and Chairman for interstitial lung disease and lung cancer to CHEST at the Summit for Respiratory Diseases from the Swiss Confederation of Pneumology Meeting in Basel
References
- ↑ Gottlieb, Daniel J.; Luisetti, Maurizio; Stone, Phillip J.; Allegra, Luigi; Cantey-Kiser, Jean M.; Grassi, Carlo; Snider, Gordon L. (2000). "Short-term Supplementation Therapy Does Not Affect Elastin Degradation in Severe α1-Antitrypsin Deficiency". American Journal of Respiratory and Critical Care Medicine. 162 (6): 2069–2072. doi:10.1164/ajrccm.162.6.2002032. PMID 11112116.
- ↑ Vacca, P.; Carbone, RG; Monselise, A.; Grosso, M.; Bottino, G. (2003). "Neurotensin pulmonary metabolism in normal and asthmatic subjects". European Review for Medical and Pharmacological Sciences. 7 (3): 75–80. PMID 14650643.
- ↑ Carbone, Roberto G.; Musi, M.; Cantalupi, D. P.; Poti, C.; Sblendorio, L. (1 October 1999). "SOMATOSTATIN RECEPTOR VERSUS GALLIUM-67 SCINTIGRAPHY IN INTERSTITIAL LUNG DISEASES". Chest. pp. 315S.
- ↑ Carbone, Roberto G.; Privitera, Vito; Montanaro, Fabio; Monselise, Assaf; Ghio, Riccardo (2007). "Emerging Indicators of Survival in Cellular and Fibrotic Nonspecific Interstitial Pneumonia". Chest. 132 (4): 457A. doi:10.1378/chest.132.4_MeetingAbstracts.457.
- ↑ Carbone, Roberto G.; Musi, M.; Cantalupi, D. P.; Poti, C.; Sblendorio, L. (1 October 1999). "SOMATOSTATIN RECEPTOR VERSUS GALLIUM-67 SCINTIGRAPHY IN INTERSTITIAL LUNG DISEASES". Chest: 315S.
- ↑ Congress, The Library of. "Carbone, Roberto G. - LC Linked Data Service: Authorities and Vocabularies | Library of Congress, from LC Linked Data Service: Authorities and Vocabularies (Library of Congress)". id.loc.gov.
- ↑ Carbone, Robertp G. "图书馆书目检索系统". opac.lib.dlut.edu.cn.
- ↑ D’Armini, Andrea Maria; Grazioli, Valentina; Viganò, Mario (2018). The History of Lung Transplantation. Lung Transplantation: Evolving Knowledge and New Horizons. Springer International Publishing. pp. 3–15. doi:10.1007/978-3-319-91184-7_1. ISBN 978-3-319-91182-3. Search this book on
- ↑ Calandriello, Lucio; Mackintosh, John; Felder, Federico; Agrawal, Aditya; Alamoudi, Omer; Alberti, Laura; Aquaro, Giuseppe; Arenas-Jiménez, Juan; Au-Yong, Iain; Avdeev, Sergey; Balbi, Maurizio; Baldi, Bruno; Ban, Andrea Yu-Lin; Belaconi, Ionela-Nicoleta; Bendstrup, Elisabeth; Bennett, David; Blum, Hans-Christian; Bariga, Nicola Boscolo; Bozovic, Gracijela; Broqi, Marsel; Bruzzi, John; Buendia-Roldan, Ivette; Calaras, Diana; Campainha, Sérgio; Carbone, Roberto G.; Carvalho, André; Cereser, Lorenzo; Chai, Gin Tsen; Chaudhary, Sachin; Chaudhuri, Nazia; Cheong, Patrick Alain Chui Wan; Cooper, Wendy; Cutaia, Giuseppe; D'Abronzo, Rosa; Kruif, Martijn D. De; Delgado-García, Diemen; Dhooria, Sahajal; Diaz-Castanon, Jesus J.; Eiger, Glenn; Ellis, Samantha; Estrada-Y-Martin, Rosa; Fang, Yingying (27 October 2023). "Late Breaking Abstract - Artificial intelligence-based decision support for HRCT stratification in fibrotic lung disease; an international study of 116 observers from 37 countries". European Respiratory Journal. doi:10.1183/13993003.congress-2023.OA4848.
- ↑ Peljto, Anna L.; et al. (2023). "Idiopathic Pulmonary Fibrosis is Associated with Common Genetic Variants and Limited Rare Variants". American Journal of Respiratory and Critical Care Medicine. 207 (9): 1194–1202. doi:10.1164/rccm.202207-1331OC. PMC 10161752 Check
|pmc=value (help). PMID 36602845 Check|pmid=value (help). - ↑ "Roberto G. Carbone Semantic Scholar". www.semanticscholar.org.
- ↑ Carbone, Roberto G. "Roberto G Carbone". www.aminer.cn.
- ↑ Carbone, Roberto G. "Carbone R - Search Results - PubMed". PubMed.
- ↑ Carbone, Roberto G. "Roberto G. Carbone peer review Journal".
- ↑ Carbone, Roberto G. "Frontiers Roberto G. Carbone".
- ↑ Carbone, Roberto G. "Roberto G. Carbone Scopus".
This article "Roberto G. Carbone" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Roberto G. Carbone. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
